本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acurx Pharmaceuticals, LLC*

1.27
-0.0050-0.39%
成交量:4.40万
成交额:5.62万
市值:692.12万
市盈率:-0.42
高:1.30
开:1.28
低:1.26
收:1.27
52周最高:7.98
52周最低:1.23
股本:547.13万
流通股本:534.27万
量比:1.20
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-3.0454
每股收益(LYR):-5.3153
净资产收益率:-128.11%
总资产收益率:-55.92%
市净率:0.85
市盈率(LYR):-0.24

数据加载中...

2026/09/08

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

SEC问询函

Form CORRESP - Correspondence
2026/05/08

SEC问询函

Form CORRESP - Correspondence
2026/05/04

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/05/04

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/10

SEC问询函

Form CORRESP - Correspondence
2026/02/02

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/02

SEC问询函

Form CORRESP - Correspondence
2025/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/09/22

重要事件披露

Form 8-K - Current report
2025/09/19

重要事件披露

Form 8-K - Current report
2025/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/31

重要事件披露

Form 8-K - Current report